GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Ellington Financial EFC · USD

Financials · US listing · 🇺🇸 United States

Compare

11.40

+1.24%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

$146.9m

FY2016FY2025

Total assets

$19.35bn

FY2016FY2025

Shareholders' equity

$1.83bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Research and development——$0$0$0$0$0$0$0$0
Operating income$415.3m$116.3m$89.2m−$25.0m$136.6m$36.4m$59.5m$103.4m$65.1m$299,000
Net income$146.9m$145.9m$84.1m−$70.0m$82.5m−$9.6m$57.9m$46.7m$6.2m−$16.0m
Diluted earnings per share1.481.631.17-1.121.46-0.221.621.470.19-0.49

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$19.35bn$16.32bn$15.32bn$14.09bn$5.18bn$3.41bn$4.34bn$3.97bn$2.99bn$2.41bn
Cash and short-term investments$201.9m$192.4m$230.5m$221.9m$92.7m$111.6m$72.5m$44.7m$47.2m$123.3m
Total liabilities$17.48bn$14.73bn$13.78bn$12.87bn$3.85bn$2.49bn$3.47bn$3.38bn$2.37bn$1.77bn
Debt$16.96bn$14.20bn$13.33bn$12.40bn$4.16bn$2.67bn$3.28bn$2.00bn$1.48bn$1.06bn
Shareholders' equity$1.83bn$1.57bn$1.52bn$1.20bn$1.32bn$921.6m$829.3m$563.8m$600.1m$637.7m
Shares outstanding99m89m72m62m57m44m36m32m32m33m

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin61.6%41.2%115.0%—112.0%116.4%69.9%—
Net margin21.8%51.7%32.8%-162.3%67.6%-30.6%——
Return on equity8.0%9.3%5.5%-5.9%6.2%-1.0%——
Return on assets0.8%0.9%0.5%-0.5%1.6%-0.3%——
Revenue growth139.0%10.0%494.5%-64.6%290.2%-63.3%——
Earnings growth0.7%73.5%-220.0%-185.0%-962.7%-116.5%——
Current ratio0.08x1.62x2.64x0.04x5.71x16.33x——
Debt to equity9.72x10.24x9.87x3.94x3.14x2.89x——
Equity ratio9.5%9.6%9.9%8.5%25.6%27.0%——
Interest coverage1.36x0.42x1.12x0.00x3.10x9.34x——
R&D as a share of sales——0.0%0.0%0.0%0.0%0.0%0.0%
Buybacks as a share of market value-11.4%-23.7%-15.8%-10.1%-29.2%-22.1%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue150.0%84.8%28.9%
Operating income—62.7%23.5%
Net income——14.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin55.6%47.4%54.5%63.9%
Net margin30.6%24.4%26.9%31.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings9.37.410.9-11.011.7-68.011.310.475.6-31.9
Price to sales2.03.83.617.97.920.87.76.343.6217.7

Market value over time

30 Nov 2016 to 30 Oct 2026, in USD

$527.0m$1.43bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return15%-8%-2%-17%6%-18%23%1%-7%-6%

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 30 Sept 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.171.561.601.801.801.641.261.81

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.